Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,173 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A fresh NAHB study finds regulatory costs have raised the typical new-home price by about $131,734, representing 26.4...
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
When a TV legend is remembered, the financial lessons behind mentorship become clear. This piece explores how a direc...
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Fidelity’s Q1 2026 data show the average IRA balance climbing to $131,380 as contributions surge. Yet the gap between...
Nasdaq’s CFO argues that AI is a leadership issue, not a back-office project. With 650 institutions using its AI-powe...
MacKenzie Scott’s philanthropy dominated megagifts in 2025, representing roughly one-third of the year’s total. New d...
NVIDIA's CEO hints that the next wave of wealth could come from skilled trades like plumbing and electrical work, pro...
A leading venture capitalist says the all-in AI trade is cracking as funding moves toward AI infrastructure and relat...
Anthropic accuses Alibaba of distillation tactics to train rival systems, prompting fresh worries about frontier AI m...
A wave of rental demand is lifting the Midwest as policy clarity and affordable development costs attract builders. A...